CRISM Therapeutics Corporation

Management Reports • Aug 23, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6752Y

Amur Minerals Corporation

23 August 2018

23 August 2018

AMUR MINERALS CORPORATION

(AIM: AMC)

Conversion of Loan and Issue of Equity

Amur Minerals Corporation ("Amur" or the "Company"), the nickel-copper sulphide mineral exploration and resource development company focused on the far east of Russia, announces that, pursuant to the convertible loan agreement entered into on 13 February 2018, the Company has today issued 3,766,649 new ordinary shares of no par value of the Company ("Ordinary Shares") to Cuart Investments PCC Ltd and YA II PN Ltd in settlement of US$165,101 of principal and accrued interest.

Application will be made to the London Stock Exchange plc for 3,766,649 new Ordinary Shares to be admitted to trading on the AIM market with admission expected to occur on or around 30 August 2018. The new Ordinary Shares rank pari passu in all respects with the existing Ordinary Shares including the right to receive any dividend or other distribution thereafter declared, made or paid.  There are no Ordinary Shares held in treasury. Therefore, the total number of voting rights in the Company, following the issue of 3,766,649 new Ordinary Shares is 666,976,680.

Market Abuse Regulation (MAR) Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

Company Amur Minerals Corp.	Nomad and Broker S.P. Angel Corporate Finance LLP	Public Relations Blytheweigh
Robin Young CEO	Ewan Leggat Soltan Tagiev	Megan Ray Tim Blythe
+7 (4212) 75 56 15	+44 (0) 20 3470 0470	+44 (0) 20 7138 3203

For additional information on the Company, visit the Company's website, www.amurminerals.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

CONGIGDICGDBGIX